[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Annual Review of Hot Spots in China's Vitamin Industry in 2014

January 2015 | 15 pages | ID: A253FCB9B55EN
Guangzhou CCM Information Science & Technology Co., Ltd. (CCM)

US$ 1,080.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Vitamin industry hot topics in 2014:
  • On 19 March, 2014, BASF released a statement, explaining that its citral production line in Germany plant had suffered a fire and had to close down. BASF's total citral capacity accounts for more than 60% of the global capacity, thus the fire led to a tight supply of citral and had a huge impact on the downstream of vitamin A, fragrance and flavor, vitamin E and other products. However, even though BASF's citral resumed production as soon as in April 2014, the domestic supply situation didn't change quickly.
  • On 11 July, 2014, DSM announced that it had reached an agreement to acquire Aland Nutraceutical, a leading producer of vitamin C in China. Through the acquisition, DSM will be able to further strengthen its status in the vitamin C market and spread its domains all over the world in human nutrition and health care, animal nutrition and health care, and personal care.
  • On 25 Oct. 2014, Shandong Haineng Bioengineering Co., Ltd. conducted a "25-hydroxyvitamin D3" press conference in International Conference Center of Jinan City, Shandong Province. Haineng Bioengineering’s launching 25-hydroxyvitamin D3 means that China is expected to break monopoly on technology and market dominated by foreign countries to some extent. And it speeds up the production and efficiency of livestock and poultry breeding.
Purpose of report:

In this report, CCM has analyzed hot spots in China's vitamin industry in 2014.

What to report:

In this report, hot spots in China's vitamin industry in 2014 have been analyzed exhaustively from the following aspects:
  • Background;
  • Company dynamics;
  • Market prices change of vitamins.
Forecasts:

In the next few years, the vitamin industry in China will continue to be promising. On the whole, it’s worth investing in it.
1 SUMMARY

2 MARKET PRICE OF FOLIC ACID HAS MAINTAINED UPWARD TREND SINCE JAN. 2014

3 FIRE HAPPENED IN GERMANY PLANT OF BASF

4 GARDEN BIOCHEMICAL SUSPENDED PRODUCTION OF CHOLESTEROL

5 DSM ACQUIRED ALAND NUTRACEUTICAL

6 XINFU PHARMACEUTICAL COMBINED TWO SUBSIDIARIES

7 25-HYDROXYVITAMIN D3 LAUNCHED BY HAINENG BIOENGINEERING

8 NEW PRODUCTION LINE OF VB3 IN NANSHA LONZA LAUNCHED

LIST OF FIGURES

Figure 2-1 Market price of folic acid in China, Jan., 2014-Nov., 2014
Figure 3-1 Market price of feed-grade VA in China, Jan., 2014-Nov., 2014
Figure 4-1 Market price of feed-grade VD3 in China, Jan., 2014 - Nov., 2014
Figure 5-1 Market price of VC in China, Jan., 2014-Nov., 2014
Figure 6-1 Market price of VB5 (Calcium pantothenate) in China, H2 2013-H1 2014
Figure 8-1 Market price of feed-grade VB3 in China, Jan., 2014 -Nov., 2014

COMPANIES MENTIONED

Changzhou Niutang Chemical Plant Co., Ltd., Changzhou Kangrui Chemical Co., Ltd., Zhejiang NHU Company Ltd., Xiamen Kingdomway Group Company, Zhejiang Medicine Co., Ltd.


More Publications